nodes	percent_of_prediction	percent_of_DWPC	metapath
Fexofenadine—ABCB1—Progesterone—uterine cancer	0.146	0.265	CbGbCtD
Fexofenadine—CYP2D6—Progesterone—uterine cancer	0.138	0.25	CbGbCtD
Fexofenadine—ABCB1—Dactinomycin—uterine cancer	0.116	0.21	CbGbCtD
Fexofenadine—ABCB1—Etoposide—uterine cancer	0.0655	0.119	CbGbCtD
Fexofenadine—ABCB1—Doxorubicin—uterine cancer	0.0447	0.0808	CbGbCtD
Fexofenadine—CYP2D6—Doxorubicin—uterine cancer	0.0421	0.0762	CbGbCtD
Fexofenadine—Paranoia—Medroxyprogesterone Acetate—uterine cancer	0.00858	0.0216	CcSEcCtD
Fexofenadine—Accidental injury—Progesterone—uterine cancer	0.0073	0.0183	CcSEcCtD
Fexofenadine—Viral infection—Progesterone—uterine cancer	0.00715	0.018	CcSEcCtD
Fexofenadine—Dysmenorrhoea—Progesterone—uterine cancer	0.0071	0.0178	CcSEcCtD
Fexofenadine—Dysmenorrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00644	0.0162	CcSEcCtD
Fexofenadine—Ear pain—Progesterone—uterine cancer	0.00549	0.0138	CcSEcCtD
Fexofenadine—Sleep disorder—Progesterone—uterine cancer	0.00542	0.0136	CcSEcCtD
Fexofenadine—Injury—Progesterone—uterine cancer	0.0051	0.0128	CcSEcCtD
Fexofenadine—Increased appetite—Progesterone—uterine cancer	0.00499	0.0125	CcSEcCtD
Fexofenadine—Thirst—Progesterone—uterine cancer	0.00493	0.0124	CcSEcCtD
Fexofenadine—Pain in extremity—Progesterone—uterine cancer	0.00469	0.0118	CcSEcCtD
Fexofenadine—Cardiac failure congestive—Medroxyprogesterone Acetate—uterine cancer	0.00468	0.0118	CcSEcCtD
Fexofenadine—Increased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00452	0.0114	CcSEcCtD
Fexofenadine—Thirst—Medroxyprogesterone Acetate—uterine cancer	0.00446	0.0112	CcSEcCtD
Fexofenadine—Infection—Carboplatin—uterine cancer	0.00436	0.0109	CcSEcCtD
Fexofenadine—Pain in extremity—Medroxyprogesterone Acetate—uterine cancer	0.00425	0.0107	CcSEcCtD
Fexofenadine—Nasopharyngitis—Progesterone—uterine cancer	0.00419	0.0105	CcSEcCtD
Fexofenadine—Psychotic disorder—Medroxyprogesterone Acetate—uterine cancer	0.00415	0.0104	CcSEcCtD
Fexofenadine—Abdominal discomfort—Progesterone—uterine cancer	0.00388	0.00976	CcSEcCtD
Fexofenadine—Nasopharyngitis—Medroxyprogesterone Acetate—uterine cancer	0.0038	0.00955	CcSEcCtD
Fexofenadine—Upper respiratory tract infection—Progesterone—uterine cancer	0.00377	0.00946	CcSEcCtD
Fexofenadine—Pain—Carboplatin—uterine cancer	0.00375	0.00943	CcSEcCtD
Fexofenadine—Pollakiuria—Progesterone—uterine cancer	0.00374	0.00941	CcSEcCtD
Fexofenadine—Chest discomfort—Etoposide—uterine cancer	0.00373	0.00938	CcSEcCtD
Fexofenadine—Drowsiness—Progesterone—uterine cancer	0.00361	0.00908	CcSEcCtD
Fexofenadine—SLCO1B3—vagina—uterine cancer	0.00359	0.0725	CbGeAlD
Fexofenadine—Abdominal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00352	0.00884	CcSEcCtD
Fexofenadine—Body temperature increased—Carboplatin—uterine cancer	0.00347	0.00871	CcSEcCtD
Fexofenadine—Upper respiratory tract infection—Medroxyprogesterone Acetate—uterine cancer	0.00341	0.00857	CcSEcCtD
Fexofenadine—Pollakiuria—Medroxyprogesterone Acetate—uterine cancer	0.00339	0.00852	CcSEcCtD
Fexofenadine—Sinusitis—Progesterone—uterine cancer	0.00339	0.00852	CcSEcCtD
Fexofenadine—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.00327	0.00823	CcSEcCtD
Fexofenadine—Epistaxis—Medroxyprogesterone Acetate—uterine cancer	0.00309	0.00776	CcSEcCtD
Fexofenadine—Sinusitis—Medroxyprogesterone Acetate—uterine cancer	0.00307	0.00772	CcSEcCtD
Fexofenadine—SLCO1B1—renal system—uterine cancer	0.00287	0.0579	CbGeAlD
Fexofenadine—Flatulence—Progesterone—uterine cancer	0.00278	0.00699	CcSEcCtD
Fexofenadine—Tension—Progesterone—uterine cancer	0.00277	0.00696	CcSEcCtD
Fexofenadine—Nervousness—Progesterone—uterine cancer	0.00274	0.00689	CcSEcCtD
Fexofenadine—Back pain—Progesterone—uterine cancer	0.00273	0.00686	CcSEcCtD
Fexofenadine—Vision blurred—Progesterone—uterine cancer	0.00266	0.00669	CcSEcCtD
Fexofenadine—Cardiac failure congestive—Etoposide—uterine cancer	0.00264	0.00664	CcSEcCtD
Fexofenadine—SLCO2B1—decidua—uterine cancer	0.00258	0.0522	CbGeAlD
Fexofenadine—Angioedema—Progesterone—uterine cancer	0.00258	0.00648	CcSEcCtD
Fexofenadine—SLCO2B1—renal system—uterine cancer	0.00254	0.0512	CbGeAlD
Fexofenadine—Flatulence—Medroxyprogesterone Acetate—uterine cancer	0.00252	0.00633	CcSEcCtD
Fexofenadine—Tension—Medroxyprogesterone Acetate—uterine cancer	0.00251	0.00631	CcSEcCtD
Fexofenadine—Palpitations—Progesterone—uterine cancer	0.00249	0.00627	CcSEcCtD
Fexofenadine—Nervousness—Medroxyprogesterone Acetate—uterine cancer	0.00248	0.00624	CcSEcCtD
Fexofenadine—Back pain—Medroxyprogesterone Acetate—uterine cancer	0.00247	0.00622	CcSEcCtD
Fexofenadine—Cough—Progesterone—uterine cancer	0.00246	0.00619	CcSEcCtD
Fexofenadine—Myalgia—Progesterone—uterine cancer	0.0024	0.00604	CcSEcCtD
Fexofenadine—Otitis media—Epirubicin—uterine cancer	0.00238	0.00598	CcSEcCtD
Fexofenadine—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.00235	0.00591	CcSEcCtD
Fexofenadine—Dry mouth—Progesterone—uterine cancer	0.00235	0.00591	CcSEcCtD
Fexofenadine—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.00234	0.00587	CcSEcCtD
Fexofenadine—SLCO1A2—renal system—uterine cancer	0.00233	0.0471	CbGeAlD
Fexofenadine—Anaphylactic shock—Progesterone—uterine cancer	0.0023	0.00579	CcSEcCtD
Fexofenadine—SLCO1B1—female reproductive system—uterine cancer	0.0023	0.0464	CbGeAlD
Fexofenadine—Infection—Progesterone—uterine cancer	0.00229	0.00575	CcSEcCtD
Fexofenadine—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.00226	0.00568	CcSEcCtD
Fexofenadine—SLCO2B1—uterus—uterine cancer	0.00226	0.0456	CbGeAlD
Fexofenadine—Tachycardia—Progesterone—uterine cancer	0.00225	0.00565	CcSEcCtD
Fexofenadine—Otitis media—Doxorubicin—uterine cancer	0.0022	0.00553	CcSEcCtD
Fexofenadine—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.00218	0.00547	CcSEcCtD
Fexofenadine—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.00213	0.00535	CcSEcCtD
Fexofenadine—Flushing—Dactinomycin—uterine cancer	0.00213	0.00535	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Progesterone—uterine cancer	0.0021	0.00528	CcSEcCtD
Fexofenadine—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00209	0.00525	CcSEcCtD
Fexofenadine—Insomnia—Progesterone—uterine cancer	0.00208	0.00524	CcSEcCtD
Fexofenadine—Infection—Medroxyprogesterone Acetate—uterine cancer	0.00207	0.00521	CcSEcCtD
Fexofenadine—Dyspnoea—Progesterone—uterine cancer	0.00205	0.00516	CcSEcCtD
Fexofenadine—Viral infection—Epirubicin—uterine cancer	0.00205	0.00515	CcSEcCtD
Fexofenadine—Somnolence—Progesterone—uterine cancer	0.00205	0.00515	CcSEcCtD
Fexofenadine—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00204	0.00512	CcSEcCtD
Fexofenadine—SLCO2B1—female reproductive system—uterine cancer	0.00203	0.041	CbGeAlD
Fexofenadine—Dyspepsia—Progesterone—uterine cancer	0.00203	0.0051	CcSEcCtD
Fexofenadine—Fatigue—Progesterone—uterine cancer	0.00199	0.00499	CcSEcCtD
Fexofenadine—Pain—Progesterone—uterine cancer	0.00197	0.00495	CcSEcCtD
Fexofenadine—HRH1—myometrium—uterine cancer	0.00196	0.0396	CbGeAlD
Fexofenadine—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.0019	0.00478	CcSEcCtD
Fexofenadine—Viral infection—Doxorubicin—uterine cancer	0.0019	0.00477	CcSEcCtD
Fexofenadine—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00189	0.00475	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Progesterone—uterine cancer	0.00188	0.00473	CcSEcCtD
Fexofenadine—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00186	0.00468	CcSEcCtD
Fexofenadine—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00186	0.00466	CcSEcCtD
Fexofenadine—SLCO2B1—female gonad—uterine cancer	0.00185	0.0373	CbGeAlD
Fexofenadine—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00184	0.00462	CcSEcCtD
Fexofenadine—Urticaria—Progesterone—uterine cancer	0.00183	0.0046	CcSEcCtD
Fexofenadine—Abdominal pain—Progesterone—uterine cancer	0.00182	0.00458	CcSEcCtD
Fexofenadine—Body temperature increased—Progesterone—uterine cancer	0.00182	0.00458	CcSEcCtD
Fexofenadine—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.0018	0.00452	CcSEcCtD
Fexofenadine—Dry eye—Epirubicin—uterine cancer	0.00171	0.0043	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00171	0.00429	CcSEcCtD
Fexofenadine—Myalgia—Dactinomycin—uterine cancer	0.0017	0.00427	CcSEcCtD
Fexofenadine—Hypersensitivity—Progesterone—uterine cancer	0.0017	0.00427	CcSEcCtD
Fexofenadine—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00166	0.00417	CcSEcCtD
Fexofenadine—Asthenia—Progesterone—uterine cancer	0.00165	0.00415	CcSEcCtD
Fexofenadine—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00165	0.00415	CcSEcCtD
Fexofenadine—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00165	0.00415	CcSEcCtD
Fexofenadine—Pruritus—Progesterone—uterine cancer	0.00163	0.0041	CcSEcCtD
Fexofenadine—Infection—Dactinomycin—uterine cancer	0.00162	0.00407	CcSEcCtD
Fexofenadine—Dry eye—Doxorubicin—uterine cancer	0.00158	0.00398	CcSEcCtD
Fexofenadine—Diarrhoea—Progesterone—uterine cancer	0.00158	0.00396	CcSEcCtD
Fexofenadine—Flushing—Etoposide—uterine cancer	0.00154	0.00387	CcSEcCtD
Fexofenadine—HRH1—epithelium—uterine cancer	0.00154	0.0311	CbGeAlD
Fexofenadine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00154	0.00387	CcSEcCtD
Fexofenadine—HRH1—uterine cervix—uterine cancer	0.00153	0.0308	CbGeAlD
Fexofenadine—Dizziness—Progesterone—uterine cancer	0.00152	0.00383	CcSEcCtD
Fexofenadine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.0015	0.00376	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00148	0.00373	CcSEcCtD
Fexofenadine—HRH1—smooth muscle tissue—uterine cancer	0.00148	0.03	CbGeAlD
Fexofenadine—Cardiac failure congestive—Epirubicin—uterine cancer	0.00148	0.00372	CcSEcCtD
Fexofenadine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00148	0.00371	CcSEcCtD
Fexofenadine—Vomiting—Progesterone—uterine cancer	0.00146	0.00368	CcSEcCtD
Fexofenadine—HRH1—decidua—uterine cancer	0.00145	0.0294	CbGeAlD
Fexofenadine—Rash—Progesterone—uterine cancer	0.00145	0.00365	CcSEcCtD
Fexofenadine—Dermatitis—Progesterone—uterine cancer	0.00145	0.00365	CcSEcCtD
Fexofenadine—Headache—Progesterone—uterine cancer	0.00144	0.00363	CcSEcCtD
Fexofenadine—Increased appetite—Epirubicin—uterine cancer	0.00143	0.0036	CcSEcCtD
Fexofenadine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00143	0.00359	CcSEcCtD
Fexofenadine—Fatigue—Dactinomycin—uterine cancer	0.0014	0.00353	CcSEcCtD
Fexofenadine—Back pain—Etoposide—uterine cancer	0.0014	0.00351	CcSEcCtD
Fexofenadine—Pain—Dactinomycin—uterine cancer	0.00139	0.0035	CcSEcCtD
Fexofenadine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00138	0.00347	CcSEcCtD
Fexofenadine—HRH1—endometrium—uterine cancer	0.00138	0.0279	CbGeAlD
Fexofenadine—Cardiac failure congestive—Doxorubicin—uterine cancer	0.00137	0.00345	CcSEcCtD
Fexofenadine—Nausea—Progesterone—uterine cancer	0.00137	0.00344	CcSEcCtD
Fexofenadine—Pain in extremity—Epirubicin—uterine cancer	0.00134	0.00338	CcSEcCtD
Fexofenadine—HRH1—mammalian vulva—uterine cancer	0.00134	0.027	CbGeAlD
Fexofenadine—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00133	0.00335	CcSEcCtD
Fexofenadine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00133	0.00334	CcSEcCtD
Fexofenadine—Increased appetite—Doxorubicin—uterine cancer	0.00132	0.00333	CcSEcCtD
Fexofenadine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00132	0.00331	CcSEcCtD
Fexofenadine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00132	0.0033	CcSEcCtD
Fexofenadine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00131	0.00329	CcSEcCtD
Fexofenadine—Abdominal pain—Dactinomycin—uterine cancer	0.00129	0.00324	CcSEcCtD
Fexofenadine—Body temperature increased—Dactinomycin—uterine cancer	0.00129	0.00324	CcSEcCtD
Fexofenadine—Cough—Etoposide—uterine cancer	0.00126	0.00317	CcSEcCtD
Fexofenadine—Pain in extremity—Doxorubicin—uterine cancer	0.00124	0.00313	CcSEcCtD
Fexofenadine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00124	0.00312	CcSEcCtD
Fexofenadine—Nasopharyngitis—Epirubicin—uterine cancer	0.0012	0.00302	CcSEcCtD
Fexofenadine—Hypersensitivity—Dactinomycin—uterine cancer	0.0012	0.00302	CcSEcCtD
Fexofenadine—SLCO2B1—lymph node—uterine cancer	0.00119	0.024	CbGeAlD
Fexofenadine—Anaphylactic shock—Etoposide—uterine cancer	0.00118	0.00296	CcSEcCtD
Fexofenadine—Infection—Etoposide—uterine cancer	0.00117	0.00294	CcSEcCtD
Fexofenadine—Asthenia—Dactinomycin—uterine cancer	0.00117	0.00294	CcSEcCtD
Fexofenadine—Tachycardia—Etoposide—uterine cancer	0.00115	0.00289	CcSEcCtD
Fexofenadine—HRH1—female reproductive system—uterine cancer	0.00114	0.0231	CbGeAlD
Fexofenadine—Diarrhoea—Dactinomycin—uterine cancer	0.00111	0.0028	CcSEcCtD
Fexofenadine—Nasopharyngitis—Doxorubicin—uterine cancer	0.00111	0.00279	CcSEcCtD
Fexofenadine—CYP2D6—renal system—uterine cancer	0.00109	0.022	CbGeAlD
Fexofenadine—Upper respiratory tract infection—Epirubicin—uterine cancer	0.00108	0.00271	CcSEcCtD
Fexofenadine—ABCB1—myometrium—uterine cancer	0.00107	0.0217	CbGeAlD
Fexofenadine—Pollakiuria—Epirubicin—uterine cancer	0.00107	0.0027	CcSEcCtD
Fexofenadine—Dyspnoea—Etoposide—uterine cancer	0.00105	0.00264	CcSEcCtD
Fexofenadine—Somnolence—Etoposide—uterine cancer	0.00105	0.00263	CcSEcCtD
Fexofenadine—HRH1—female gonad—uterine cancer	0.00104	0.021	CbGeAlD
Fexofenadine—Drowsiness—Epirubicin—uterine cancer	0.00104	0.0026	CcSEcCtD
Fexofenadine—Vomiting—Dactinomycin—uterine cancer	0.00104	0.0026	CcSEcCtD
Fexofenadine—HRH1—vagina—uterine cancer	0.00103	0.0209	CbGeAlD
Fexofenadine—Rash—Dactinomycin—uterine cancer	0.00103	0.00258	CcSEcCtD
Fexofenadine—Fatigue—Etoposide—uterine cancer	0.00102	0.00255	CcSEcCtD
Fexofenadine—Pain—Etoposide—uterine cancer	0.00101	0.00253	CcSEcCtD
Fexofenadine—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000999	0.00251	CcSEcCtD
Fexofenadine—Pollakiuria—Doxorubicin—uterine cancer	0.000993	0.0025	CcSEcCtD
Fexofenadine—Epistaxis—Epirubicin—uterine cancer	0.000977	0.00246	CcSEcCtD
Fexofenadine—Sinusitis—Epirubicin—uterine cancer	0.000972	0.00244	CcSEcCtD
Fexofenadine—Nausea—Dactinomycin—uterine cancer	0.000967	0.00243	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Etoposide—uterine cancer	0.000964	0.00242	CcSEcCtD
Fexofenadine—Drowsiness—Doxorubicin—uterine cancer	0.000958	0.00241	CcSEcCtD
Fexofenadine—Urticaria—Etoposide—uterine cancer	0.000936	0.00235	CcSEcCtD
Fexofenadine—Abdominal pain—Etoposide—uterine cancer	0.000932	0.00234	CcSEcCtD
Fexofenadine—Body temperature increased—Etoposide—uterine cancer	0.000932	0.00234	CcSEcCtD
Fexofenadine—Epistaxis—Doxorubicin—uterine cancer	0.000904	0.00227	CcSEcCtD
Fexofenadine—Sinusitis—Doxorubicin—uterine cancer	0.000899	0.00226	CcSEcCtD
Fexofenadine—CYP2D6—female reproductive system—uterine cancer	0.00087	0.0176	CbGeAlD
Fexofenadine—Hypersensitivity—Etoposide—uterine cancer	0.000868	0.00218	CcSEcCtD
Fexofenadine—Flushing—Epirubicin—uterine cancer	0.000863	0.00217	CcSEcCtD
Fexofenadine—Asthenia—Etoposide—uterine cancer	0.000846	0.00213	CcSEcCtD
Fexofenadine—ABCB1—epithelium—uterine cancer	0.000843	0.017	CbGeAlD
Fexofenadine—ABCB1—uterine cervix—uterine cancer	0.000835	0.0169	CbGeAlD
Fexofenadine—Pruritus—Etoposide—uterine cancer	0.000834	0.0021	CcSEcCtD
Fexofenadine—Diarrhoea—Etoposide—uterine cancer	0.000806	0.00203	CcSEcCtD
Fexofenadine—Flushing—Doxorubicin—uterine cancer	0.000799	0.00201	CcSEcCtD
Fexofenadine—Flatulence—Epirubicin—uterine cancer	0.000798	0.002	CcSEcCtD
Fexofenadine—ABCB1—decidua—uterine cancer	0.000796	0.0161	CbGeAlD
Fexofenadine—Tension—Epirubicin—uterine cancer	0.000794	0.002	CcSEcCtD
Fexofenadine—CYP2D6—female gonad—uterine cancer	0.000792	0.016	CbGeAlD
Fexofenadine—Nervousness—Epirubicin—uterine cancer	0.000786	0.00198	CcSEcCtD
Fexofenadine—Back pain—Epirubicin—uterine cancer	0.000783	0.00197	CcSEcCtD
Fexofenadine—ABCB1—renal system—uterine cancer	0.000782	0.0158	CbGeAlD
Fexofenadine—Dizziness—Etoposide—uterine cancer	0.000779	0.00196	CcSEcCtD
Fexofenadine—Vision blurred—Epirubicin—uterine cancer	0.000763	0.00192	CcSEcCtD
Fexofenadine—ABCB1—endometrium—uterine cancer	0.000756	0.0153	CbGeAlD
Fexofenadine—Vomiting—Etoposide—uterine cancer	0.000749	0.00188	CcSEcCtD
Fexofenadine—Agitation—Epirubicin—uterine cancer	0.000744	0.00187	CcSEcCtD
Fexofenadine—Rash—Etoposide—uterine cancer	0.000743	0.00187	CcSEcCtD
Fexofenadine—Dermatitis—Etoposide—uterine cancer	0.000742	0.00187	CcSEcCtD
Fexofenadine—Headache—Etoposide—uterine cancer	0.000738	0.00186	CcSEcCtD
Fexofenadine—Flatulence—Doxorubicin—uterine cancer	0.000738	0.00185	CcSEcCtD
Fexofenadine—Tension—Doxorubicin—uterine cancer	0.000735	0.00185	CcSEcCtD
Fexofenadine—ABCB1—mammalian vulva—uterine cancer	0.000731	0.0148	CbGeAlD
Fexofenadine—Nervousness—Doxorubicin—uterine cancer	0.000727	0.00183	CcSEcCtD
Fexofenadine—Back pain—Doxorubicin—uterine cancer	0.000725	0.00182	CcSEcCtD
Fexofenadine—Palpitations—Epirubicin—uterine cancer	0.000715	0.0018	CcSEcCtD
Fexofenadine—Cough—Epirubicin—uterine cancer	0.000706	0.00178	CcSEcCtD
Fexofenadine—Vision blurred—Doxorubicin—uterine cancer	0.000706	0.00177	CcSEcCtD
Fexofenadine—Nausea—Etoposide—uterine cancer	0.0007	0.00176	CcSEcCtD
Fexofenadine—ABCB1—uterus—uterine cancer	0.000696	0.0141	CbGeAlD
Fexofenadine—Myalgia—Epirubicin—uterine cancer	0.000689	0.00173	CcSEcCtD
Fexofenadine—Agitation—Doxorubicin—uterine cancer	0.000688	0.00173	CcSEcCtD
Fexofenadine—Dry mouth—Epirubicin—uterine cancer	0.000674	0.00169	CcSEcCtD
Fexofenadine—HRH1—lymph node—uterine cancer	0.000669	0.0135	CbGeAlD
Fexofenadine—Palpitations—Doxorubicin—uterine cancer	0.000662	0.00166	CcSEcCtD
Fexofenadine—Anaphylactic shock—Epirubicin—uterine cancer	0.000661	0.00166	CcSEcCtD
Fexofenadine—Infection—Epirubicin—uterine cancer	0.000656	0.00165	CcSEcCtD
Fexofenadine—Cough—Doxorubicin—uterine cancer	0.000654	0.00164	CcSEcCtD
Fexofenadine—Tachycardia—Epirubicin—uterine cancer	0.000645	0.00162	CcSEcCtD
Fexofenadine—Myalgia—Doxorubicin—uterine cancer	0.000638	0.0016	CcSEcCtD
Fexofenadine—ABCB1—female reproductive system—uterine cancer	0.000626	0.0126	CbGeAlD
Fexofenadine—Dry mouth—Doxorubicin—uterine cancer	0.000624	0.00157	CcSEcCtD
Fexofenadine—Anaphylactic shock—Doxorubicin—uterine cancer	0.000611	0.00154	CcSEcCtD
Fexofenadine—Infection—Doxorubicin—uterine cancer	0.000607	0.00153	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000602	0.00151	CcSEcCtD
Fexofenadine—Insomnia—Epirubicin—uterine cancer	0.000598	0.0015	CcSEcCtD
Fexofenadine—Tachycardia—Doxorubicin—uterine cancer	0.000597	0.0015	CcSEcCtD
Fexofenadine—Dyspnoea—Epirubicin—uterine cancer	0.000589	0.00148	CcSEcCtD
Fexofenadine—Somnolence—Epirubicin—uterine cancer	0.000587	0.00148	CcSEcCtD
Fexofenadine—Dyspepsia—Epirubicin—uterine cancer	0.000582	0.00146	CcSEcCtD
Fexofenadine—Fatigue—Epirubicin—uterine cancer	0.00057	0.00143	CcSEcCtD
Fexofenadine—ABCB1—female gonad—uterine cancer	0.00057	0.0115	CbGeAlD
Fexofenadine—ABCB1—vagina—uterine cancer	0.000566	0.0114	CbGeAlD
Fexofenadine—Pain—Epirubicin—uterine cancer	0.000565	0.00142	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000557	0.0014	CcSEcCtD
Fexofenadine—Insomnia—Doxorubicin—uterine cancer	0.000553	0.00139	CcSEcCtD
Fexofenadine—Dyspnoea—Doxorubicin—uterine cancer	0.000545	0.00137	CcSEcCtD
Fexofenadine—Somnolence—Doxorubicin—uterine cancer	0.000543	0.00137	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Epirubicin—uterine cancer	0.00054	0.00136	CcSEcCtD
Fexofenadine—Dyspepsia—Doxorubicin—uterine cancer	0.000538	0.00135	CcSEcCtD
Fexofenadine—Fatigue—Doxorubicin—uterine cancer	0.000527	0.00132	CcSEcCtD
Fexofenadine—Urticaria—Epirubicin—uterine cancer	0.000525	0.00132	CcSEcCtD
Fexofenadine—Pain—Doxorubicin—uterine cancer	0.000523	0.00131	CcSEcCtD
Fexofenadine—Abdominal pain—Epirubicin—uterine cancer	0.000522	0.00131	CcSEcCtD
Fexofenadine—Body temperature increased—Epirubicin—uterine cancer	0.000522	0.00131	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Doxorubicin—uterine cancer	0.0005	0.00126	CcSEcCtD
Fexofenadine—Hypersensitivity—Epirubicin—uterine cancer	0.000487	0.00122	CcSEcCtD
Fexofenadine—Urticaria—Doxorubicin—uterine cancer	0.000486	0.00122	CcSEcCtD
Fexofenadine—Abdominal pain—Doxorubicin—uterine cancer	0.000483	0.00121	CcSEcCtD
Fexofenadine—Body temperature increased—Doxorubicin—uterine cancer	0.000483	0.00121	CcSEcCtD
Fexofenadine—Asthenia—Epirubicin—uterine cancer	0.000474	0.00119	CcSEcCtD
Fexofenadine—Pruritus—Epirubicin—uterine cancer	0.000467	0.00117	CcSEcCtD
Fexofenadine—Diarrhoea—Epirubicin—uterine cancer	0.000452	0.00114	CcSEcCtD
Fexofenadine—Hypersensitivity—Doxorubicin—uterine cancer	0.00045	0.00113	CcSEcCtD
Fexofenadine—Asthenia—Doxorubicin—uterine cancer	0.000439	0.0011	CcSEcCtD
Fexofenadine—Dizziness—Epirubicin—uterine cancer	0.000437	0.0011	CcSEcCtD
Fexofenadine—Pruritus—Doxorubicin—uterine cancer	0.000433	0.00109	CcSEcCtD
Fexofenadine—Vomiting—Epirubicin—uterine cancer	0.00042	0.00106	CcSEcCtD
Fexofenadine—Diarrhoea—Doxorubicin—uterine cancer	0.000418	0.00105	CcSEcCtD
Fexofenadine—Rash—Epirubicin—uterine cancer	0.000417	0.00105	CcSEcCtD
Fexofenadine—Dermatitis—Epirubicin—uterine cancer	0.000416	0.00105	CcSEcCtD
Fexofenadine—Headache—Epirubicin—uterine cancer	0.000414	0.00104	CcSEcCtD
Fexofenadine—Dizziness—Doxorubicin—uterine cancer	0.000404	0.00102	CcSEcCtD
Fexofenadine—Nausea—Epirubicin—uterine cancer	0.000392	0.000986	CcSEcCtD
Fexofenadine—Vomiting—Doxorubicin—uterine cancer	0.000389	0.000977	CcSEcCtD
Fexofenadine—Rash—Doxorubicin—uterine cancer	0.000385	0.000969	CcSEcCtD
Fexofenadine—Dermatitis—Doxorubicin—uterine cancer	0.000385	0.000968	CcSEcCtD
Fexofenadine—Headache—Doxorubicin—uterine cancer	0.000383	0.000962	CcSEcCtD
Fexofenadine—ABCB1—lymph node—uterine cancer	0.000366	0.0074	CbGeAlD
Fexofenadine—Nausea—Doxorubicin—uterine cancer	0.000363	0.000912	CcSEcCtD
